Eileen M O’Reilly (@EileenMOReilly) / X

Eileen M O’Reilly

5,571 posts

Eileen M O’Reilly

@EileenMOReilly

Oncologist MSK. TCD alum. Interests Pancreas, genomics, Hepatobiliary, GI Cancers, IRB Chair, Editor, Drug Development, Clinical trials, Alliance GI, NCTN

Manhattan, NY

mskcc.org/cancer-care/do…

Joined May 2019

Pinned
Eileen M O’Reilly
@EileenMOReilly
Jun 5, 2023
Exciting to see these results out! Lots to build on - congratulations @ superb MSK pancreas team (no biases!) and complex insightful analyses led by @CentralParkWMD @MSKCancerCenter and as #ASCO23 winds down…. back to the real work of implementing all the learnings to practice!
Wungki Park, MD MS
@CentralParkWMD
Jun 5, 2023
Pembro + olaparib maintenece #POLAR trial (B&C) in non-BRCA potential #HRD stage IV #PancreaticCancer n=30. Well-tolerated. 30% had no progression for > 6mo WITHOUT chemo. Deep science & POLAR A #BRCA awaited. #gratitude & 💜to MSK team & patients #ASCO23 t.ly/D9gl
28K
Eileen M O’Reilly
@EileenMOReilly
Jul 19, 2023
Thank you so much for the wonderful honor and privilege to be @PanCAN’s next Chair of the Scientific and Medical Advisory Board and to work with this amazing group of people, colleagues, friends, advocacy community and more. Thanks to everyone for all the kind words!
PanCAN
@PanCAN
Jul 18, 2023
We're thrilled to announce Eileen M. O'Reilly, MD from @MSKCancerCenter as the new Chair of PanCAN's Scientific and Medical Advisory Board (SMAB)! Dr. O'Reilly is the principal investigator of multiple #pancreaticcancer clinical trials, including PanCAN's Precision Promise
26K
Eileen M O’Reilly
@EileenMOReilly
Sep 22, 2022
Thrilled re MSK Panc SPORE active! Many thanks @theNCI, amazing team of scientists, advocacy & pancreas community! @ciacobu @W_Park_MD @dana_peer @LewisLabMSKCC @MSKCancerCenter @OlcaBasturk @letswinpc @wei_ac @MSK_DeptOfMed @TheVinodLab @CpcrMsk @NatPancFdn @MFBerger1
Eileen M O’Reilly
@EileenMOReilly
Dec 16, 2023
Amazing and super that pancreas cancer is in the #1 pole position for most cited article ever in @JCO_ASCO - it was fun to write this commentary with @AndrewKo and esteemed Editor in Chief @DrJFriedberg
Journal of Clinical Oncology
@JCO_ASCO
Dec 15, 2023
Celebrating JCO's 40th: Congrats to the #1 most cited #JCO article of the past 40 years! 'Gemcitabine For Advanced Pancreas Cancer' by @BurrisSkip et al. (1997). Read the Flashback Foreword by @EileenMOReilly, Andrew L. Ko, MD, @DrJFriedberg 👉 brnw.ch/21wFmYc #OncTwitter
24K
Eileen M O’Reilly
@EileenMOReilly
Jun 2, 2023
Many many congratulations-⁦@ferguskeane2⁩ ⁦⁦@YJanjigianMD (Chief & mentor)⁩ @DrSamuelCytryn - very talented MSK oncology Fellows - Conquer Cancer Young Investigator and Merit awards!⁦@MSK_DeptOfMed⁩ ⁦@MSKCancerCenter⁩ ⁦@CentralParkWMD⁩ ⁦
22K
Eileen M O’Reilly
@EileenMOReilly
Jun 4, 2023
Privileged and honored to present the exciting data in KRASmut panc and CRC - terrific team of investigators @DrShubhamPant @pashtoonkasi and many more and really wonderful translational science @MSKCancerCenter @MSK_DeptOfMed @ElicioTx and team #ASCO23
Dr. Shubham Pant
@DrShubhamPant
Jun 3, 2023
🤩🤩 to be a collaborator and senior author on this important trial testing a #KRAS vaccine in patients to prevent recurrence. Presented by amazing collaborator and colleague @EileenMOReilly @MDAndersonNews @MSKCancerCenter @OncoAlert @ASCO @Aiims1742 meetings.asco.org/abstracts-pres…
16K
Eileen M O’Reilly
@EileenMOReilly
Dec 17, 2020
A nice snowy festive view from my office in NYC...
Eileen M O’Reilly
@EileenMOReilly
Oct 1, 2022
Please join us 11/18/2022 MSK Pancreas Cancer Symposium! All star @DrVickersMSK @GMPetersen1 @SharifEllozy #RohitChandawani @CFerroneMD @MichaelDAngeli2 @wei_ac @W_Park_MD @MSKCancerCenter @CpcrMsk @DrRichardDo @TheVinodLab @MFBerger1 @drpeterkingham
Eileen M O’Reilly
@EileenMOReilly
Nov 2, 2024
Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort academic.oup.com/jnci/article-a… Congrats to @ferguskeane2 @CatherineaOC @FiyinfoluB @DrewMoss for very thoughtful compilation synthesis of data!
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic...
From academic.oup.com
6.8K
Eileen M O’Reilly
@EileenMOReilly
Dec 30, 2019
Terrific to see olaparib FDA approved today for gBRCA related pancreas cancer as maintenance therapy. Adds an option for subset of people @CpcrMsk @NEJM @TaliaGolan and many others including AZ, Merck!
Eileen M O’Reilly
@EileenMOReilly
Jun 5, 2022
Thank you - all credit to the really compelling science led by @TheVinodLab and a tremendous team @CpcrMsk @MSKCancerCenter @W_Park_MD @KevinCSoaresMD @OlcaBasturk @bengrbm @gonen_mithat and more. Looking forward to next steps! #ASCO2022 #PancreaticCancer
This Post is from an account that no longer exists. Learn more
Eileen M O’Reilly
@EileenMOReilly
Sep 1, 2021
I have to admit some bias here 🙂- but truly a renaissance man @GABOUALFA ! @sloan_kettering @FordhamLawNYC @Columbia_Biz
Rebecca Williams
@RWilliams_MSK
Aug 31, 2021
The doc that does it all! Thank you, @GABOUALFA for all you do @sloan_kettering and beyond! #backtoschool news.law.fordham.edu/blog/2021/08/2…
Eileen M O’Reilly
@EileenMOReilly
Jan 2, 2021
Here are some early exciting data to get 2021 started in pancreas...collaboration between several centers and Parker Inst, Cancer Res Inst and Others- awaiting randomized phase II authors.elsevier.com/c/1cKZ05EIIgBX…
Eileen M O’Reilly
@EileenMOReilly
Sep 1, 2023
We are so lucky at MSK to have @ferguskeane2 as part of our pancreas(+hepatobiliary) teams for the last two years! Many congratulations on all your successes and new consultant role in Dublin, Ireland!! The irish diaspora and all your friends here at MSK will miss you stateside!
Wungki Park, MD MS
@CentralParkWMD
Aug 31, 2023
Congratulations, Dr. Keane! @ferguskeane2 Much deserved! @MSK_DeptOfMed Will miss you~ Advanced oncology fellowship is very successful!! Make us proud in 🇮🇪! You will be amazing~ @EileenMOReilly @GABOUALFA @Sam_Cytryn @MHLars
6.6K